Anthem Biosciences Limited (NSE:ANTHEM)

India · Delayed Price · Currency is INR

670.15

+10.00 (1.51%)

At close: Mar 10, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Contract Research Development & Manufacturing Services (CRDMO)	13.06B	8.98B	8.08B	9.47B	9.96B
Contract Research Development & Manufacturing Services (CRDMO) Growth	45.44%	11.08%	-14.69%	-4.94%	-
Speciality Ingredients	3.38B	3.36B	2.49B	2.84B	1.07B
Speciality Ingredients Growth	0.68%	35.11%	-12.40%	165.96%	-
R & D Services	2.01B	1.86B	-	-	-
R & D Services Growth	8.09%	-	-	-	-
Total	18.45B	14.19B	10.57B	12.31B	11.03B
Total Growth	29.96%	34.29%	-14.16%	11.60%	-

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
North America (USA)	4.87B	4.29B	5.00B	5.18B	5.64B
North America (USA) Growth	13.70%	-14.31%	-3.38%	-8.19%	-
Europe	10.07B	6.13B	3.06B	4.60B	2.86B
Europe Growth	64.20%	100.35%	-33.38%	60.58%	-
India	3.06B	3.10B	2.13B	2.32B	1.60B
India Growth	-1.32%	45.34%	-8.08%	45.05%	-
Rest of Asia & Others	443.66M	676.71M	374.95M	222.01M	-
Rest of Asia & Others Growth	-34.44%	80.48%	68.89%	-	-
Rest of Asia	-	-	-	-	868.20M
Others	-	-	-	-	65.70M
Total	18.45B	14.19B	10.57B	12.31B	11.03B
Total Growth	29.96%	34.29%	-14.16%	11.60%	-

Source: S&P Global Market Intelligence.